Tentolouris, A., Eleftheriadou, I., & Tentolouris, N. (2018). Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes. Ann Transl Med.
Style de citation ChicagoTentolouris, Anastasios, Ioanna Eleftheriadou, et Nikolaos Tentolouris. "Insulin Degludec U100 Is Associated With Lower Risk for Severe and Symptomatic Hypoglycemia As Compared With Insulin Glargine U100 in Subjects With Type 1 Diabetes." Ann Transl Med 2018.
Style de citation MLATentolouris, Anastasios, Ioanna Eleftheriadou, et Nikolaos Tentolouris. "Insulin Degludec U100 Is Associated With Lower Risk for Severe and Symptomatic Hypoglycemia As Compared With Insulin Glargine U100 in Subjects With Type 1 Diabetes." Ann Transl Med 2018.